Anika Therapeutics, Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Anika Therapeutics, Inc. (ANIK) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $647.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2019-02-27
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-12-31 was $247.00K.
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-09-30 was $0.00.
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-06-30 was $100.00K.
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $647.00K, a 23.61% decline from fiscal 2015.
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $847.00K, a 91.20% decline from fiscal 2014.
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $9.63M, a 1023.22% increase from fiscal 2013.
- Anika Therapeutics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $857.00K, a 89.40% increase from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $247.00K derived: sum of 2 quarters · filed 2019-02-27 | $347.00K derived: sum of 3 quarters · filed 2019-02-27 | $647.00K 10-K · filed 2019-02-27 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-10-27 | $100.00K derived: sum of 2 quarters · filed 2017-10-27 | $400.00K 10-Q · filed 2017-10-27 | ||
| 2016-06-30 | $100.00K 10-Q · filed 2017-07-28 | $400.00K 10-Q · filed 2017-07-28 | |||
| 2015-12-31 | $847.00K 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | $9.63M 10-K · filed 2017-02-24 | $9.63M 10-K · filed 2015-03-13 | |||
| 2013-12-31 | $857.00K 10-K · filed 2016-03-10 | $856.83K 10-K · filed 2014-03-13 | |||
| 2012-12-31 | $452.47K 10-K · filed 2015-03-13 | ||||
| 2011-12-31 | $274.19K 10-K · filed 2014-03-13 | ||||
| 2010-12-31 | -$21.19K 10-K · filed 2013-03-14 | ||||
| 2009-12-31 | -$82.54K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |